Italy· 027253020
TORADOL
A ketorolac product containing ketorolac, registered in Italy by RECORDATI INDUSTRIA CHIMICA FARMACEUTICA S.P.A., on the national reimbursement list. The same ATC class is registered in 9 of our 19 countries.
Checked against AIFA (Italy) on
Informational only — not a medical device.
Where it is registered
Ketorolac is registered in 9 of 19 countries.
Countries holding a registration under ATC M01AB15 (ketorolac), each read from that country’s own register.
- This record: Italy, from AIFA (Italy)
- 6 of them publish a price we can compare per daily dose
Ketorolac · ATC M01AB15
9 / 19 countries
- Canada
- Denmark
- Finlandprice
- Icelandprice
- Italyprice
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ketorolac costs, country by country.
Normalised to the WHO defined daily dose (30 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ketorolac · price per daily dose (30 mg)
USD · FX 28 Sept 2026
- US United States$0.49 (acquisition cost)
The record
At a glance
AIFA (Italy)- Active substance
- Ketorolac
- Manufacturer
- RECORDATI INDUSTRIA CHIMICA FARMACEUTICA S.P.A.
- Country
- Italy (IT)
- ATC code
- M01AB15
- ATC class
- Ketorolac
- Defined daily dose
- 30 mg, O
- Reimbursed
- Yes
- Source register
- AIFA (Italy)
- Last checked
- September 28, 2026
Packs & prices · 1
1 priced- aic027253020"30 MG/ML SOLUZIONE INIETTABILE" 3 FIALEEUR 2.16
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
378 interactions on record for ketorolac.
Graded by severity as the source publishes them — 69 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ketorolac · interactions on record
378 records
- 69 severe
- 129 moderate
- 5 minor
- 94 info
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- DalteparinB01AB04severe
- EnoxaparinB01AB05severe
81 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ketorolac in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainKETOROLACO KABI 30 MG/ML SOLUCION INYECTABLE EFGFresenius Kabi España, S.A.U.
- SwedenKetorolac S.A.L.F. 30 mg/ml Injektionsvätska, lösningS.A.L.F. SpA Laboratorio Farmacologico
- NorwayKetorolac trometamol S.A.L.F.S.A.L.F S.p.A. Laboratorio Farmacologico
- IcelandToradolAtnahs Pharma Netherlands B.V.
- United StatesAcularAllergan, Inc.
- United KingdomAcular 0.5% eye dropsSigma Pharmaceuticals Plc
- CanadaACULARABBVIE CORPORATION
- CzechiaKETOROLAC TROMETAMOL BROWN & BURKBrown & Burk IR Limited, Dublin
Authorised across Europe · EMA
The same active substance is authorised in 23 EEA countries. Names it is sold under:
- Austria · Acular, Ketorolac Micro Labs
- Belgium · Aculare, Taradyl
- Bulgaria · Кетоажур, Кеторолак Вижън
- Cyprus · Errkes
- Czechia · Ketorolac Trometamol Brown & Burk
- Germany · Ketorolac Micro Labs, Ketovision
- Denmark · Acular, Caloket
- Estonia · Ketorolac Baxter
- Spain · Acular, Ketorolaco Kabi
- Finland · Caloket, Ketorolac S.A.L.F.
- France · Acular
- United Kingdom (Northern Ireland) · Acular, Ketorolac Trometamol Baxter Healthcare
- Greece · Acular, Errkes
- Ireland · Acular
- Iceland · Toradol
- Lithuania · Ketanov, Ketorolac Baxter
- Luxembourg · Aculare, Taradyl
- Latvia · Ketanov, Ketorolac Baxter
- Norway · Caloket, Ketorolac Trometamol S.A.L.F.
- Poland · Ketorolac Trometamol Brown & Burk
- Portugal · Acular, Cetorolac
- Romania · Ketanov, Ketorol
- Sweden · Caloket, Ketorolac S.A.L.F.
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AIFA (Italy). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b0e96186-0ddc-408e-8cb7-6e1033aded45 GET /v1/drugs/b0e96186-0ddc-408e-8cb7-6e1033aded45?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pack": "\"30 MG/ML SOLUZIONE INIETTABILE\" 3 FIALE",
"source": "aifa",
"currency": "EUR",
"substance": "Ketorolac",
"reference_pack": "3 UNITA' 30 MG - USO PARENTERALE",
"public_price_eur": 2.16,
"ssn_reference_price_eur": 4.06
}See everything about ketorolac.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.